CONMED Corporation is a medical devices business based in the US. CONMED Corporation shares (CNMD) are listed on the NYSE and all prices are listed in US Dollars. CONMED Corporation employs 3,400 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in CONMED Corporation
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CNMD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- CNMD shares summary
- Compare share dealing platforms
- Is CNMD stock a buy or sell?
- Stock performance over time
- Can I short CNMD shares?
- Are CNMD shares over-valued?
- CONMED Corporation's financials
- How volatile are CNMD shares?
- Does CONMED Corporation pay a dividend?
- Have CNMD shares ever split?
- Other common questions
CONMED Corporation stock price (NYSE: CNMD)Use our graph to track the performance of CNMD stocks over time.
CONMED Corporation shares at a glance
|Latest market close||$137.69|
|52-week range||$71.12 - $146.74|
|50-day moving average||$136.18|
|200-day moving average||$130.10|
|Wall St. target price||$157.75|
|Dividend yield||$0.8 (0.58%)|
|Earnings per share (TTM)||$0.44|
Buy CONMED Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy CONMED Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
CONMED Corporation price performance over time
|1 week (2021-07-21)||N/A|
|1 month (2021-07-01)||-0.77%|
|3 months (2021-04-30)||-2.31%|
|6 months (2021-01-28)||N/A|
|1 year (2020-07-28)||N/A|
|2 years (2019-07-28)||N/A|
|3 years (2018-07-28)||N/A|
|5 years (2016-07-28)||N/A|
Is CONMED Corporation under- or over-valued?
Valuing CONMED Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CONMED Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CONMED Corporation's P/E ratio
CONMED Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 312x. In other words, CONMED Corporation shares trade at around 312x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
CONMED Corporation's PEG ratio
CONMED Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.29. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CONMED Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CONMED Corporation's EBITDA
CONMED Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $142.2 million.
The EBITDA is a measure of a CONMED Corporation's overall financial performance and is widely used to measure a its profitability.
CONMED Corporation financials
|Revenue TTM||$881.1 million|
|Operating margin TTM||8.45%|
|Gross profit TTM||$477 million|
|Return on assets TTM||2.66%|
|Return on equity TTM||1.89%|
|Market capitalisation||$4 billion|
TTM: trailing 12 months
Shorting CONMED Corporation shares
There are currently 846,967 CONMED Corporation shares held short by investors – that's known as CONMED Corporation's "short interest". This figure is 17.2% down from 1.0 million last month.
There are a few different ways that this level of interest in shorting CONMED Corporation shares can be evaluated.
CONMED Corporation's "short interest ratio" (SIR)
CONMED Corporation's "short interest ratio" (SIR) is the quantity of CONMED Corporation shares currently shorted divided by the average quantity of CONMED Corporation shares traded daily (recently around 100114.30260047). CONMED Corporation's SIR currently stands at 8.46. In other words for every 100,000 CONMED Corporation shares traded daily on the market, roughly 8460 shares are currently held short.
However CONMED Corporation's short interest can also be evaluated against the total number of CONMED Corporation shares, or, against the total number of tradable CONMED Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CONMED Corporation's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 CONMED Corporation shares in existence, roughly 60 shares are currently held short) or 0.0622% of the tradable shares (for every 100,000 tradable CONMED Corporation shares, roughly 62 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against CONMED Corporation.
Find out more about how you can short CONMED Corporation stock.
CONMED Corporation share dividends
Dividend payout ratio: 35.09% of net profits
Recently CONMED Corporation has paid out, on average, around 35.09% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.58% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CONMED Corporation shareholders could enjoy a 0.58% return on their shares, in the form of dividend payments. In CONMED Corporation's case, that would currently equate to about $0.8 per share.
While CONMED Corporation's payout ratio might seem fairly standard, it's worth remembering that CONMED Corporation may be investing much of the rest of its net profits in future growth.
CONMED Corporation's most recent dividend payout was on 5 July 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 June 2021 (the "ex-dividend date").
Have CONMED Corporation's shares ever split?
CONMED Corporation's shares were split on a 3:2 basis on 9 September 2001. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your CONMED Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for CONMED Corporation shares which in turn could have impacted CONMED Corporation's share price.
CONMED Corporation share price volatility
Over the last 12 months, CONMED Corporation's shares have ranged in value from as little as $71.1235 up to $146.7354. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CONMED Corporation's is 1.5609. This would suggest that CONMED Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
CONMED Corporation overview
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida. .
Stocks similar to CONMED Corporation
CONMED Corporation in the news
CONMED Corporation 2021 Q2 - Results - Earnings Call Presentation
Conmed Corp (CNMD) Q2 2021 Earnings Call Transcript
CONMED's (CNMD) Q2 Earnings Surpass Estimates, '21 View Up
Frequently asked questionsWhat percentage of CONMED Corporation is owned by insiders or institutions?
Currently 0.777% of CONMED Corporation shares are held by insiders and 109.097% by institutions. How many people work for CONMED Corporation?
Latest data suggests 3,400 work at CONMED Corporation. When does the fiscal year end for CONMED Corporation?
CONMED Corporation's fiscal year ends in December. Where is CONMED Corporation based?
CONMED Corporation's address is: 11311 Concept Boulevard, Largo, FL, United States, 33773-4908 What is CONMED Corporation's ISIN number?
CONMED Corporation's international securities identification number is: US2074101013 What is CONMED Corporation's CUSIP number?
CONMED Corporation's Committee on Uniform Securities Identification Procedures number is: 207410101
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert